HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

DEAR DR. ROACH: I’m a 75-year-old woman who, for at least 10 years now, has been experiencing a rapid heart rate. My blood ...

The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...

As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

Currently, Garmin’s ECG functionality only extends to on-the-spot readings and works to distinguish between normal sinus rhythms and signs of atrial fibrillation (AFib).

AI reveals hidden patterns in ECGs that human experts can't see, transforming a century-old clinical tool into a powerful ...

Excessive supraventricular ectopic activity (ESVEA) in the acute phase of ischemic stroke or transient ischemic attack (TIA) ...